Evidence map›Paper›PMID 37302399›Full record

ArticleThe lancet. HIV2023

HIV infection and engagement in the care continuum among migrants and refugees from Venezuela in Colombia: a cross-sectional, biobehavioural survey.

Andrea L Wirtz, José Rafael Guillén, Megan Stevenson, Jennifer Ortiz, Miguel Ángel Barriga Talero, Kathleen R Page, Jhon Jairo López, Damary Martínez Porras, Jhon Fredy Ramirez Correa, Ricardo Luque Núñez and 2 more

Open access · greenAbstract read
In one paragraph

Article in The lancet. HIV, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. HIV-infected Latin American asylum seekers in Madrid, Spain, 2022: A prospective cohort study from a major gateway in Europe.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Andrea L WirtzDepartment of Epidemiology, Center for Public Health and Human Rights, Johns Hopkins University, Baltimore, MD, USA; Bloomberg School of Public Health, Department of International Health, Center for Humanitarian Health, Johns Hopkins University, Baltimore, MD, USA. Electronic address: awirtz1@jhu.edu.
José Rafael GuillénRed Somos, Bogotá, Colombia.
Megan StevensonDepartment of Epidemiology, Center for Public Health and Human Rights, Johns Hopkins University, Baltimore, MD, USA.
Jennifer OrtizRed Somos, Bogotá, Colombia.
Miguel Ángel Barriga TaleroRed Somos, Bogotá, Colombia.
Kathleen R PageDepartment of Epidemiology, Center for Public Health and Human Rights, Johns Hopkins University, Baltimore, MD, USA; Bloomberg School of Public Health, Department of International Health, Center for Humanitarian Health, Johns Hopkins University, Baltimore, MD, USA; Department of Infectious Disease, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Jhon Jairo LópezRed Somos, Bogotá, Colombia.
Damary Martínez PorrasRed Somos, Bogotá, Colombia.
Jhon Fredy Ramirez CorreaRed Somos, Bogotá, Colombia.
Ricardo Luque NúñezMinistry of Health and Social Protection, Bogotá, Colombia.
Julián A Fernández-NiñoDepartment of International Health, Johns Hopkins University, Baltimore, MD, USA.
Paul B SpiegelBloomberg School of Public Health, Department of International Health, Center for Humanitarian Health, Johns Hopkins University, Baltimore, MD, USA.
Johns Hopkins University · USJohns Hopkins Medicine · USMinistry of Health and Social Protection · CO

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
CDC HHS NU2GGH002000NIAID NIH HHS P30 AI094189
6 · The paper itself

Abstract

backgroundVenezuela has experienced substantial human displacement since 2015. To inform HIV programmes and treatment distribution, we aimed to estimate HIV prevalence and associated indicators among migrants and refugees from Venezuela residing in Colombia, the largest receiving country.

methodsWe conducted a biobehavioural, cross-sectional survey using respondent-driven sampling among Venezuelan people aged 18 years or older who had arrived in Colombia since 2015 and resided in four cities (ie, Bogotá, Soacha, Soledad, and Barranquilla). Participants completed sociobehavioural questionnaires and rapid HIV and syphilis screening with laboratory-based confirmatory testing, CD4 cell counts, and viral load quantification. Policies related to migration status affect access to insurance and HIV services in Colombia, as in many receiving countries, so we provided legal assistance and navigation support to participants with HIV for sustained access to treatment. Population-based estimates were weighted for the complex sampling design. Penalised multivariable logistic regression analysis was used to identify correlates of viral suppression (HIV-1 RNA <1000 copies per mL).

findingsBetween July 30, 2021, and Feb 5, 2022, 6506 participants were recruited through respondent-driven sampling, of whom 6221 were enrolled. 4046 (65·1%) of 6217 were cisgender women, 2124 (34·2%) of 6217 were cisgender men, and 47 (0·8%) of 6217 were transgender or non-binary people. 71 (1·1%) of all 6221 participants had laboratory-confirmed HIV infection, resulting in a weighted population HIV prevalence of 0·9% (95% CI 0·6-1·4). Among participants living with HIV, 34 (47·9%) of 71 had been previously diagnosed with HIV and 25 (35·7%) of 70 had viral suppression. Individuals with irregular migration status compared with individuals with regular migration status (adjusted odds ratio 0·3, 95% CI 0·1-0·9) and with a most recent HIV test in Colombia compared with a most recent test in Venezuela (0·2, 0·1-0·8) were less likely to have suppressed viral loads.

interpretationHIV prevalence among migrants and refugees from Venezuela in Colombia suggests the HIV epidemic is close to being generalised, which could be addressed by the inclusion of migrants and refugees from Venezuela in local HIV services, improved access to and navigation support for HIV testing and care, and coordination with humanitarian programmes. There is an association between migration status and viral suppression, conferring both clinical and epidemiological implications. Therefore, legal support and access to insurance might lead to early detection of HIV and timely treatment for people with irregular migration status.

fundingUS President's Emergency Plan for AIDS Relief through the US Centers for Disease Control and Prevention. TRANSLATION: For the Spanish translation of the abstract see Supplementary Materials section.

Indexed as

HIV InfectionsRefugeesTransients and MigrantsColombiaContinuity of Patient CareCross-Sectional StudiesFemaleHumansMaleVenezuela

Identifiers

PMID37302399
PMCPMC10336726
OpenAlexW4379801621

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.